HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital.

Abstract
We studied 1,020 patients with hypertension visiting our outpatient clinic during a five-year period, from 1995 until 1999. Those subjects were screened by determining plasma renin activity (PRA) and plasma aldosterone concentration (PAC) after testing routine laboratory examinations in order to differentiate secondary hypertension from essential hypertension. All patients with low-reninemic hypertension were examined by furosemide plus the upright test. This led to an increase in diagnoses of primary aldosteronism (PA) (confirmed by captopril-loading test). Our studies demonstrated that the incidence of PA is 5.4%, and also that the plasma potassium level is not always beneficial for suspecting the presence of PA, because 28% of the patients with PA show only hypokalemia. We would like to emphasize that adrenal venous sampling plays a critical role in establishing the optimal management for patients with PA, because CT imaging is limited to detection of adrenal masses.
AuthorsT Nishikawa, M Omura
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 54 Suppl 1 Pg. 83s-85s (Jun 2000) ISSN: 0753-3322 [Print] France
PMID10914999 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Furosemide
  • Captopril
Topics
  • Adrenal Glands (diagnostic imaging)
  • Angiotensin-Converting Enzyme Inhibitors
  • Captopril
  • Diuretics
  • Furosemide
  • Humans
  • Hyperaldosteronism (diagnosis, epidemiology, physiopathology)
  • Hypertension (etiology)
  • Japan (epidemiology)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: